Axia Journal of Oncology Case Reports (AJOCR)

Open science is essential to solving the world’s urgent challenges

About

Supporting researchers to open up every output from their research, including publications and preprints, data, code, protocols, methods, and peer review.

By enabling researchers to share their research openly, together we can increase its use and re-use, speed up scientific advances, deliver efficiencies for research, foster collaboration between disciplines, enable easier translation into economic and societal impact, and improve trust in science. That’s why we support open science across all academic disciplines. By enabling open science practices, and collaborating with partners across the scholarly ecosystem, faster and more effective research systems can be created that operate sustainably and at scale and build an equitable research landscape. 

Aims and Scope – Axia Journal of Oncology Case Reports (AJOCR)

The Axia Journal of Oncology Case Reports (AJOCR) is a peer-reviewed, open-access journal dedicated to publishing detailed case reports that provide valuable insights into oncology, including rare cancer cases, novel therapeutic approaches, and unique clinical presentations. Our mission is to serve as a platform for oncologists, pathologists, researchers, and healthcare professionals to share real-world clinical experiences that contribute to medical knowledge and improve patient outcomes.

Scope:

  • Rare and Uncommon Cancer Cases – Case studies on rare malignancies and unusual tumor presentations.
  • Novel Cancer Treatments – Reports on new chemotherapy, immunotherapy, targeted therapy, and personalized medicine approaches.
  • Oncologic Surgery Case Reports – Complex tumor resections, minimally invasive procedures, and innovative surgical techniques.
  • Radiation Oncology Cases – Reports on stereotactic radiotherapy, proton therapy, and radiation toxicity management.
  • Hematologic Malignancies – Leukemia, lymphoma, multiple myeloma, and bone marrow transplantation case studies.
  • Pediatric Oncology Cases – Unique pediatric cancer presentations, treatment challenges, and outcomes.
  • Metastatic and Advanced Cancers – Case studies detailing treatment strategies for late-stage cancer patients.
  • Immuno-Oncology and CAR-T Therapy – Case reports on immune checkpoint inhibitors, CAR-T cell therapy, and monoclonal antibodies.
  • Oncologic Emergencies – Cases involving tumor lysis syndrome, spinal cord compression, and febrile neutropenia.
  • Paraneoplastic Syndromes – Uncommon cancer-associated syndromes and their clinical management.
  • Genomic and Molecular Oncology Cases – Tumor biomarker-driven treatment responses and genetic mutation discoveries.
  • Oncology Imaging and Diagnostics – PET-CT, MRI, and novel imaging modalities for cancer detection and monitoring.
  • Palliative and Supportive Oncology – Pain management, end-of-life care, and symptom control case reports.
  • Unusual Treatment Responses – Exceptional responses to experimental or off-label therapies.
  • Multidisciplinary Tumor Board Case Discussions – Collaborative case reports involving different specialties in oncology care.

AJOCR serves oncologists, radiation oncologists, surgical oncologists, hematologists, pathologists, radiologists, and researchers dedicated to advancing oncology case-based knowledge and clinical practice.

The journal follows a rigorous peer-review process, ensures international visibility through indexing in major scientific databases, and promotes rapid publication to disseminate impactful oncology case reports.

Keywords

Oncology Case Reports Rare Cancers Novel Cancer Treatments Oncologic Surgery Radiation Oncology Immuno-Oncology CAR-T Cell Therapy Checkpoint Inhibitors Hematologic Malignancies Pediatric Oncology Metastatic Cancer Tumor Biomarkers Precision Oncology Cancer Imaging Paraneoplastic Syndromes Oncologic Emergencies Multidisciplinary Cancer Care Personalized Cancer Therapy Experimental Cancer Treatments Palliative Oncology Tumor Board Case Discussions Molecular Oncology Rare Tumor Presentations Chemotherapy Resistance Cancer Survivorship

Peer Review Process

 As an academic publisher, Axia Scientific Publishers ensures that open access makes cutting-edge research widely accessible, enabling it to be read, shared, and built upon. This fosters interdisciplinary knowledge exchange, informs policy-making, and benefits the general public.

Manuscript Submission

Explore how to publish your research article, book, or chapter with Axia Scientific Publishers and make your work widely accessible.

Open access enhances research visibility, increases citations, and promotes trust and reproducibility—benefiting researchers, institutions, and their funders.

Assignment to Reviewers

Our dedicated support team assists authors in identifying potential open access funding sources and provides guidance on the application process.

Peer Review Evaluation

Axia Scientific Publishers supports transformative open access agreements, streamlining funding and workflows to accelerate the transition to open research.